Literature DB >> 2902865

Impaired T-lymphocyte-dependent immune responses to microbial antigens in patients with HIV-1-associated persistent generalized lymphadenopathy.

J J Ballet1, L J Couderc, C Rabian-Herzog, C Duval-Roy, M Janier, F Danon, J P Clauvel, M Seligmann.   

Abstract

T-cell mediated and humoral responses directed to microbial antigens were investigated, at the time of the initial visit, in a group of 139 patients with HIV-1-related persistent generalized lymphadenopathy (PGL) enrolled in a longitudinal study. In vivo and in vitro cell-mediated responses to tuberculin were lower in patients than in controls. Differences were not significant for candidin and streptococcal antigen in vitro, whereas higher responses were observed in the patient group for cytomegalovirus antigen. Following immunization, a subgroup of patients did not have a significantly raised serum antitetanus antibody level, whereas in vitro lymphocyte proliferative responses to tetanus toxoid were lower than in controls. No association was found between these abnormalities and other immunological parameters, including the blood level of CD4+ lymphocytes. Lower responses to most microbial antigens were observed in patients with HIV-1-related symptoms in addition to lymphadenopathy, or the patients who progressed to AIDS in the 2 years following the study. Moreover, intravenous drug users showed higher responses than homosexual patients, possibly because of the influence of previous infections on immunological responses to microbial antigens.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2902865     DOI: 10.1097/00002030-198808000-00009

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  10 in total

1.  Spontaneous release of interferon as a predictor of clinical evolution in HIV-positive subjects.

Authors:  A Biglino; A Surbone; F Lipani; N Cappello; B Forno; A M Pollono; M Busso; A Pugliese
Journal:  Infection       Date:  1991 Jan-Feb       Impact factor: 3.553

2.  Reconstitution of CD4+ T cell responses in HIV-1 infected individuals initiating highly active antiretroviral therapy (HAART) is associated with renewed interleukin-2 production and responsiveness.

Authors:  G A D Hardy; N Imami; A K Sullivan; A Pires; C T Burton; M R Nelson; B G Gazzard; F M Gotch
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

3.  Autoproliferation in HIV-1-infected patients undergoing active HIV-1-specific immunotherapy.

Authors:  R J Trauger; W Giermakowska; S Wormsley; J Turner; F C Jensen; D J Carlo
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

Review 4.  Immune dysregulation and CD4+ T cell loss in HIV-1 infection.

Authors:  L Meyaard; F Miedema
Journal:  Springer Semin Immunopathol       Date:  1997

5.  Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency.

Authors:  S L Waldrop; C J Pitcher; D M Peterson; V C Maino; L J Picker
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

6.  Immune responses to fractionated cytomegalovirus (CMV) antigens after HIV infection. Loss of cellular and humoral reactivity to antigens recognized by HIV-, CMV+ individuals.

Authors:  P J Converse; T E Fehniger; A Ehrnst; O Strannegård; S Britton
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

7.  Nonradioactive techniques for measurement of in vitro T-cell proliferation: alternatives to the [(3)H]thymidine incorporation assay.

Authors:  T Messele; M T Roos; D Hamann; M Koot; A L Fontanet; F Miedema; P T Schellekens; T F Rinke de Wit
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

8.  Cell-mediated immunity to HIV-1 in Walter Reed stages 1-6 individuals: correlation with virus burden.

Authors:  R J Trauger; W K Giermakowska; F Ferre; P C Duffy; M R Wallace; D E Lewis; H J Beecham; K G Burnett; F C Jensen; D J Carlo
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

9.  Effects of IL-2 therapy in asymptomatic HIV-infected individuals on proliferative responses to mitogens, recall antigens and HIV-related antigens.

Authors:  A D Kelleher; M Roggensack; S Emery; A Carr; M A French; D A Cooper
Journal:  Clin Exp Immunol       Date:  1998-07       Impact factor: 4.330

10.  Low frequency of plasma nerve-growth factor detection is associated with death of memory B lymphocytes in HIV-1 infection.

Authors:  K Titanji; A Nilsson; C Mörch; A Samuelsson; A Sönnerborg; S Grutzmeier; M Zazzi; A De Milito
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.